Results for pneumonia and bronchiolitis were less than 70% at this stage andsubmission (FDA) for these diseases will occur in a second phase.
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-20
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #